Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 4Unknown 2Terminated 2Active not recruiting 1

Sponsor Class

OTHER 100INDUSTRY 11OTHER_GOV 4NETWORK 4NIH 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1

Conditions

Breast Neoplasms 179Leukemia 162Lymphoma 116Lung Neoplasms 107Carcinoma, Non-Small-Cell Lung 99Precursor Cell Lymphoblastic Leukemia-Lymphoma 97Central Nervous System Neoplasms 84Sarcoma 82Prostatic Neoplasms 81Ovarian Neoplasms 76Colorectal Neoplasms 71Head and Neck Neoplasms 70Leukemia, Myeloid, Acute 60Squamous Cell Carcinoma of Head and Neck 54Rectal Neoplasms 54Neuroblastoma 52Colonic Neoplasms 52Multiple Myeloma 51Uterine Cervical Neoplasms 47Brain Neoplasms 46Lymphoma, Large B-Cell, Diffuse 45Leukemia, Lymphocytic, Chronic, B-Cell 41Carcinoma, Ovarian Epithelial 41Burkitt Lymphoma 41Astrocytoma 40Glioblastoma 39Fallopian Tube Neoplasms 39Neoplasm Metastasis 38Congenital Abnormalities 37Lymphoma, Follicular 36

Interventions

Observation 1IMM-101 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × NETWORK × COVID-19 × Clear all
NCT04442048 2025-12-30

COV-IMMUNO

Canadian Cancer Trials Group

Phase 3 Completed
195 enrolled

COVID-19, Neoplasms

NCT05386355 2025-03-11

MoVeUP

IDeA States Pediatric Clinical Trials Network

Phase NA Completed
1,934 enrolled 11 charts
LymphoidOther hematologic neoplasm

COVID-19, Vaccination Hesitancy, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04492371 2024-03-05

EMN-COVID

European Myeloma Network B.V.

Completed
1,054 enrolled
Plasma cell

COVID-19, Multiple Myeloma, Coronavirus Infections

NCT04422470 2023-01-26

CHRONOS19

National Research Center for Hematology, Russia

Completed
666 enrolled
LymphoidOther hematologic neoplasm

COVID-19, Hematologic Diseases, Leukemia, Lymphoma, Coronavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡